Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, July 6, 2020 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa Labs” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 15, 2020, to shareholders of record at the close of…

Mesa Labs Reports Record Second Quarter Revenues and Adjusted Operating Income

Lakewood, Colorado, November 6, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record second quarter revenues and adjusted operating income (“AOI”) for the three months ended September 30, 2019. Financial Highlights In comparison to the same quarter in the prior year, second quarter revenues increased 3% to $25.5M,…

Mesa Labs Acquires Gyros Protein Technologies

Lakewood, Colorado, October 31, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a diversified supplier of quality control instruments and consumables to highly regulated markets today announced the acquisition of Gyros Protein Technologies Holding AB (“GPT”). GPT is headquartered in Uppsala, Sweden and is a leading provider of Immunoassay and…

Mesa Laboratories, Inc. Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options

Mesa Laboratories, Inc. Announces Closing of Public Offerings of Common Stock and Convertible Senior Notes, Including Full Exercise of Underwriters’ Options Source: Mesa Laboratories, Inc. – August 12, 2019 4:05 PM ET Lakewood, Colo., Aug. 12, 2019 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the closing of its previously announced concurrent…

Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Mesa Laboratories, Inc. Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes Source: Mesa Laboratories, Inc. – August 7, 2019 11:20 PM ET Lakewood, Colo., Aug. 07, 2019 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced the pricing of concurrent underwritten public offerings of (a) 375,000 shares of its…

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock and Convertible Senior Notes Source: Mesa Laboratories, Inc. – August 6, 2019 4:05 PM ET LAKEWOOD, Colo., Aug. 06, 2019 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ: MLAB) (“Mesa”) today announced that it has commenced concurrent underwritten public offerings of 375,000 shares of its common…

Mesa Labs Reports Record First Quarter Revenues and Adjusted Operating Income

Mesa Labs Reports Record First Quarter Revenues and Adjusted Operating Income Lakewood, Colorado, July 30, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today reported record first quarter revenues and adjusted operating income1 (“AOI”) for the three months ended June 30, 2019. Financial Highlights In comparison to the same quarter…

Mesa Labs Declares Quarterly Dividend

MESA LABS DECLARES QUARTERLY DIVIDEND Lakewood, Colorado, July 9, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on September 16, 2019, to shareholders of record…

Mesa Labs Declares Quarterly Dividend

Lakewood, Colorado, April 8, 2019 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of $0.16 per share of common stock. The dividend will be payable on June 14, 2019, to shareholders of record at the close of business…